Stay updated on ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.4, replacing v3.5.3 and signaling a newer release. This metadata update does not change the visible content or functionality of the page.
    Difference
    0.1%
    Check dated 2026-05-16T00:00:24.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page’s displayed revision/version has been updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:12.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:40:55.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The site revision label has been updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T19:27:25.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:11:43.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-lapse notice and the older Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T09:23:33.000Z thumbnail image

Stay in the know with updates to ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.